N-acylsulfonamide apoptosis promoters

Abstract

Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and methods of treatment of diseases during which occurs expression of one or more than one of an anti-apoptotic protein family member using the compounds.

1 . A compound having formula (I)  
       
         
           
           
               
               
           
         
       
       or a therapeutically acceptable salt, prodrug, salt of a prodrug or metabolite thereof, wherein 
 A 1  is N or C(A 2 );  
 one or two or three or each of A 2 , B 1 , D 1  and E 1  are independently selected R 1 , OR 1 , SR 1 , S(O)R 1 , SO 2 R 1 , C(O)R 1 , C(O)OR 1 , OC(O)R 1 , NHR 1 , N(R 1 ) 2 , C(O)NHR 1 , C(O)N(R 1 ) 2 , NHC(O)R 1 , NHC(O)OR 1 , NR 1 C(O)NHR 1 , NR 1 C(O)N(R 1 ) 2 , SO 2 NHR 1 , SO 2 N(R 1 ) 2 , NHSO 2 R 1 , NHSO 2 NHR 1  or N(CH 3 )SO 2 N(CH 3 )R 1 , and the remainder are independently selected H, F, Cl, Br, I, CN, CF 3 , C(O)OH, C(O)NH 2  or C(O)OR 1A ; and  
 Y 1  is H, CN, NO 2 , C(O)OH, F, Cl, Br, I, CF 3 , OCF 3 , CF 2 CF 3 , OCF 2 CF 3 , R 17 , OR 17 , C(O)R 17 , C(O)OR 17 , SR 17 , NH 2 , NHR 17 , N(R 17 ) 2 , NHC(O)R 17 , C(O)NH 2 , C(O)NHR 17 , C(O)N(R 17 ) 2 , NHS(O)R 17  or NHSO 2 R 17 ; or  
 B 1  and Y 1 , together with the atoms to which they are attached, are imidazole or triazole; and  
 one or two or each of A 2 , D 1  and E 1  are independently selected R 1 , OR 1 , SR 1 , S(O)R 1 , SO 2 R 1 , C(O)R 1 , C(O)OR 1 , OC(O)R 1 , NHR 1 , N(R 1 ) 2 , C(O)NHR 1 , C(O)N(R 1 ) 2 , NHC(O)R 1 , NHC(O)OR 1 , NHC(O)NHR 1 , N(CH 3 )C(O)N(CH 3 )R 1 , SO 2 NHR 1 , SO 2 N(R 1 ) 2 , NHSO 2 R 1 , NHSO 2 NHR 1  or N(CH 3 )SO 2 N(CH 3 )R 1 , and the remainder are independently selected H, F, Cl, Br, I, CF 3 , C(O)OH, C(O)NH 2  or C(O)OR 1A ;  
 R 1  is R 2 , R 3 , R 4  or R 5 ;  
 R 1A  is C 1 -C 6 -alkyl, C 3 -C 6 -alkenyl or C 3 -C 6 -alkynyl;  
 R 2  is phenyl which is unfused or fused with arene, heteroarene or R 2A ; R 2A  is cycloalkane or heterocycloalkane;  
 R 3  is heteroaryl which is unfused or fused with benzene, heteroarene or R 3A ; R 3A  is cycloalkane or heterocycloalkane;  
 R 4  is cycloalkyl, cycloalkenyl, heterocycloalkyl or heterocycloalkenyl, each of which is unfused or fused with arene, heteroarene or R 4A ; R 4A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 5  is alkyl, alkenyl or alkynyl, each of which is unsubstituted or substituted with one or two or three independently selected R 6 , NC(R 6A )(R 6B ), R 7 , OR 7 , SR 7 , S(O)R 7 , SO 2 R 7 , NHR 7 , N(R 7 ) 2 , C(O)R 7 , C(O)NH 2 , C(O)NHR 7 , NHC(O)R 7 , NHSO 2 R 7 , NHC(O)OR 7 , SO 2 NH 2 , SO 2 NHR 7 , SO 2 N(R 7 ) 2 , NHC(O)NH 2 , NHC(O)NHR 7 , NHC(O)CH(CH 3 )NHC(O)CH(CH 3 )NH 2 , NHC(O)CH(CH 3 )NHC(O)CH(CH 3 )NHR 1 , OH, (O), C(O)OH, (O), N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;  
 R 6  is C 2 -C 5 -spiroalkyl, each of which is unsubstituted or substituted with OH, (O), N 3 , CN, CF 3 , CF 2 CF 3 , F, Cl, Br, I, NH 2 , NH(CH 3 ) or N(CH 3 ) 2 ;  
 R 6A  and R 6B  are independently selected alkyl or, together with the N to which they are attached, R 6C ;  
 R 6C  is aziridin-1-yl, azetidin-1-yl, pyrrolidin-1-yl or piperidin-1-yl, each having one CH 2  moiety unreplaced or replaced with O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH;  
 R 7  is R 8 , R 9 , R 10  or R 11 ;  
 R 8  is phenyl which is unfused or fused with arene, heteroarene or R 8A ;  
 R 8A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 9  is heteroaryl which is unfused or fused with arene, heteroarene or R 9A ; R 9A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 10  is C 3 -C 10 -cycloalkyl or C 4 -C 10 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N, and each of which is unfused or fused with arene, heteroarene or R 10A ; R 10A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 11  is alkyl, alkenyl or alkynyl, each of which is unsubstituted or substituted with one or two or three independently selected R 12 , OR 12 , NHR 12 , N(R 12 ) 2 , C(O)NH 2 , C(O)NHR 12 , C(O)N(R 12 ) 2 , OH, (O), C(O)OH, N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;  
 R 12  is R 13 , R 14 , R 15  or R 16 ;  
 R 13  is phenyl which is unfused or fused with arene, heteroarene or R 13A ; R 13A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 14  is heteroaryl, each of which is unfused or fused with arene, heteroarene or R 14A ; R 14A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 15  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene, each of which is unfused or fused with arene, heteroarene or R 15A ; R 15A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 16  is alkyl, alkenyl or alkynyl;  
 R 17  is R 18 , R 19 , R 20  or R 21 ;  
 R 18  is phenyl which is unfused or fused with arene, heteroarene or R 18A ; R 18A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 19  is heteroaryl which is unfused or fused with arene, heteroarene or R 19A ; R 19A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 20  is C 3 -C 10 -cycloalkyl or C 4 -C 10 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N, and each of which is unfused or fused with arene, heteroarene or R 20A ; R 20A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 21  is alkyl, alkenyl or alkynyl, each of which is unsubstituted or substituted with one or two or three independently selected R 22 , OR 22 , NHR 22 , N(R 22 ) 2 , C(O)NH 2 , C(O)NHR 22 , C(O)N(R 22 ) 2 , OH, (O), C(O)OH, N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;  
 R 22  is R 23 , R 24  or R 25 ;  
 R 23  is phenyl which is unfused or fused with arene, heteroarene or R 23A ; R 23A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 24  is heteroarene which is unfused or fused with arene, heteroarene or R 24A ; R 24A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 25  is C 3 -C 6 -cycloalkyl or C 4 -C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N, and each of which is unfused or fused with arene, heteroarene or R 25A ; R 25A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 Z 1  is R 26  or R 27 , each of which is substituted with R 28 , R 29  or R 30 , each of which is substituted with F, Cl, Br, I, CH 2 R 37 , CH(R 31 )(R 37 ), C(R 31 )(R 31A )(R 37 ), X(O)R 37 , OR 37 , SR 37 , S(O)R 37 , SO 2 R 37 , NHR 37  or N(R 32 )R 37 ;  
 R 26  is phenyl which is unfused or fused with arene or heteroarene;  
 R 27  is heteroarene which is unfused or fused with arene or heteroarene;  
 R 28  is phenyl which is unfused or fused with arene, heteroarene or R 28A ; R 28A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene  
 R 29  is heteroaryl or R 29A ; R 29A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 30  is cycloalkyl or cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N, and each of which is unfused or fused with arene, heteroarene or R 30A ; R 30A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 31  and R 31A  are independently F, Cl, Br or alkyl or are taken together and are C 2 -C 5 -spiroalkyl;  
 R 32  is R 33 , C(O)R 33  or C(O)OR 33 ;  
 R 33  is R 34  or R 35 ;  
 R 34  is phenyl which is unfused or fused with aryl, heteroaryl or R 34A ; R 34A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 35  is alkyl which is unsubstituted or substituted with R 36 ;  
 R 36  is phenyl which is unfused or fused with arene, heteroarene or R 36A ; R 36A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 37  is R 38 , R 39  or R 40 , each of which is substituted with F, Cl, Br, I, R 41  OR 41 , NHR 41 , N(R 41 ) 2 , NHC(O)OR 41 , SR 41 , S(O)R 41  or SO 2 R 41 ;  
 R 38  is phenyl which is unfused or fused with arene, heteroarene or R 38A ; R 38A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 39  is heteroaryl which is unfused or fused with arene, heteroarene or R 39A ; R 39A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 40  is C 3 -C 8 -cycloalkyl or C 4 -C 8 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N, and each of which is unfused or fused with arene, heteroarene or R 40A ; R 40A  cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 41  is R 42 , R 43 , R 44  or R 45 ;  
 R 42  is phenyl which is unfused or fused with arene, heteroarene or R 42A ; R 42A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 43  is heteroaryl which is unfused or fused with arene, heteroarene or R 43A ; R 43A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 44  is C 3 -C 6 -cycloalkyl or C 4 -C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N, and each of which is unfused or fused with arene, heteroarene or R 44A ; R 44A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 45  is alkyl, alkenyl or alkynyl, each of which is unsubstituted or substituted with one or two independently selected R 46 , OR 46  NHR 46 , N(R 46 ) 2 , C(O)NH 2 , C(O)NHR 46 , C(O)N(R 46 ) 2 , OH, (O), C(O)OH, N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;  
 R 46  is R 47 , R 48  or R 49 ;  
 R 47  is phenyl which is unfused or fused with arene, heteroarene or R 47A ; R 47A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 48  is heteroaryl or R 48A ; R 48A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 49  is C 3 -C 6 -cycloalkyl or C 4 -C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N, and each of which is unfused or fused with arene, heteroarene or R 49A ; R 49A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 wherein each foregoing cyclic moiety is independently unsubstituted, further unsubstituted, substituted or further substituted with one or two or three or four or five independently selected R 50 , OR 50 , SR 50 , S(O)R 50 , SO 2 R 50 , C(O)R 50 , CO(O)R 50 , OC(O)R 50 , OC(O)OR 50 , NH 2 , NHR 50 , N(R 50 ) 2 , C(O)NH 2 , C(O)NHR 50 , C(O)N(R 50 ) 2 , C(O)NHOH, C(O)NHOR 50 , C(O)NHSO 2 R 50 , C(O)NR 55 SO 2 R 50 , SO 2 NH 2 , SO 2 NHR 50 , SO 2 N(R 50 ) 2 , CF 3 , CF 2 CF 3 , C(O)H, C(O)OH, C(N)NH 2 , C(N)NHR 50 , C(N)N(R 50 ) 2 , OH, (O), N 3 , NO 2 , CF 3 , CF 2 CF 3 , OCF 3 , OCF 2 CF 3 , F, Cl, Br or I substituents;  
 R 50  is R 51 , R 52 , R 53  or R 54 ;  
 R 51  is phenyl which is unfused or fused with arene, heteroarene or R 51A ; R 51A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 52  is heteroaryl or R 52A ; R 52A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 53  is C 3 -C 6 -cycloalkyl or C 4 -C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N, and each of which is unfused or fused with arene, heteroarene or R 53A ; R 53A  is cycloalkane, cycloalkene, heterocycloalkane or heterocycloalkene;  
 R 54  is alkyl, alkenyl or alkynyl, each of which is unsubstituted or substituted with one or two or three independently selected R 55 , OR 55 , SR 55 , S(O)R 55 , SO 2 R 55 , NHR 55 , N(R 55 ) 2 , C(O)R 55 , C(O)NH 2 , C(O)NHR 55 , NHC(O)R 55 , NHSO 2 R 55 , NHC(O)OR 55 , SO 2 NH 2 , SO 2 NHR 55 , SO 2 N(R 55 ) 2 , NHC(O)NH 2 , NHC(O)NHR 55 , OH, (O), C(O)OH, (O), N 3 , CN, NH 2 , CF 3 , OCF 3 , CF 2 CF 3 , OCF 2 CF 3 , F, Cl, Br or I substituents;  
 R 55  is alkyl, alkenyl, alkynyl, phenyl, heteroaryl or R 56 ;  
 R 56  is C 3 -C 6 -cycloalkyl or C 4 -C 6 -cycloalkyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N.  
 
     
     
         2 . The compound of formula (I) according to  claim 1 , wherein A 1  s N or C(A  2 ); 
 A 2  is H, F, CN, C(O)OH, C(O)NH 2  or C(O)OR 1A ;    B 1  is R 1 , OR 1 , SR 1 , S(O)R 1 , SO 2 R 1 , C(O)R 1 , C(O)OR 1 , OC(O)R 1 , NHR 1 , N(R 1 ) 2 , C(O)NHR 1 , C(O)N(R 1 ) 2 , NHC(O)R 1 , NHC(O)OR 1 , NR 1 C(O)NHR 1 , NR 1 C(O)N(R 1 ) 2 , SO 2 NHR 1 , SO 2 N(R 1 ) 2 , NHSO 2 R 11 , NHSO 2 NHR 1  or N(CH 3 ) SO 2 N(CH 3 )R 1 ;    D 1  is H, F, C 1  or CF 3 ;    E 1  is H, F or Cl;    Y 1  is H, CN, NO 2 , C(O)OH, F, Cl, Br, I, CF 3 , OCF 3 , CF 2 CF 3 , OCF 2 CF 3 , R 17 , OR 17 , C(O)R 17 , C(O)OR 17 , SR 17 , NH 2 , NHR 17 , N(R 17 ) 2 , NHC(O)R 17 , C(O)NH 2 , C(O)NHR 17 , C(O)N(R 17 ) 2 , NHS(O)R 17  or NHSO 2 R 17 ; or    B 1  and Y 1 , together with the atoms to which they are attached, are imidazole or triazole;    R 1  is R 2 , R 3 , R 4  or R 5 ;    R 1A  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl, C 6 -alkyl;    R 2  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 3  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 4  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl or C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 5  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl, C 6 -alkyl, C 2 -alkenyl, C 3 -alkenyl, C 4 -alkenyl, C 5 -alkenyl, C 6 -alkenyl, C 3 -alkynyl, C 4 -alkynyl, C 5 -alkynyl or C 6 -alkynyl, each of which is unsubstituted or substituted with one or two or three independently selected R 6 , R 7 , OR 7 , SR 7 , S(O)R 7 , SO 2 R 7 , NHR 7 , N(R 7 ) 2 , C(O)R 7 , C(O)NH 2 , C(O)NHR 7 , NHC(O)R 7 , NHSO 2 R 7 , NHC(O)OR 7 , SO 2 NH 2 , SO 2 NHR 7 , SO 2 N(R 7 ) 2 , NHC(O)NH 2 , NHC(O)NHR 7 , NHC(O)CH(CH 3 )NHC(O)CH(CH 3 )NH 2 , OH, (O), C(O)OH, (O), N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;    R 6  is C 2 -spiroalkyl, C 3 -spiroalkyl, C 4 -spiroalkyl or C 5 -spiroalkyl, each of which is unsubstituted or substituted with OH, (O), N 3 , CN, CF 3 , CF 2 CF 3 , F, Cl, Br, I, NH 2 , NH(CH 3 ) or N(CH 3 ) 2 ;    R 7  is R 8 , R 9 , R 10  or R 11 ;    R 8  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine, 1,2,3-triazole or R 8A ;    R 8A  is C 4 -cycloalkane, C 5 -cycloalkane, C 6 -cycloalkane, C 4 -cycloalkene, C 5 -cycloalkene or C 6 -cycloalkene, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 9  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 10  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 7 -cycloalkyl, C 8 -cycloalkyl, C 9 -cycloalkyl, C 10 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl, C 6 -cycloalkenyl, C 7 -cycloalkenyl, C 8 -cycloalkenyl, C 9 -cycloalkenyl, C 10 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 11  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl C 6 -alkyl, C 2 -alkenyl, C 3 -alkenyl, C 4 -alkenyl, C 5 -alkenyl C 6 -alkenyl, C 2 -alkynyl, C 3 -alkynyl, C 4 -alkynyl, C 5 -alkynyl or C 6 -alkynyl, each of which is unsubstituted or substituted with one or two or three independently selected R 12 , OR 12 , NHR 12 , N(R 12 ) 2 , C(O)NH 2 , C(O)NHR 12 , C(O)N(R 12 ) 2 , OH, (O), C(O)OH, N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;    R 12  is R 13 , R 14 , R 15  or R 16 ;    R 13  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine, 1,2,3-triazole or R 13A ;    R 13A  is C 4 -cycloalkane, C 5 -cycloalkane, C 6 -cycloalkane, C 4 -cycloalkene, C 5 -cycloalkene or C 6 -cycloalkene, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 14  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl, 1,2,3-triazolyl, each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 15  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl or C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 16  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl C 6 -alkyl, C 2 -alkenyl, C 3 -alkenyl, C 4 -alkenyl, C 5 -alkenyl C 6 -alkenyl, C 3 -alkynyl, C 4 -alkynyl, C 5 -alkynyl or C 6 -alkynyl;    R 17  is R 18 , R 19 , R 20  or R 21 ;    R 18  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 19  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 20  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 7 -cycloalkyl, C 8 -cycloalkyl, C 9 -cycloalkyl, C 10 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl, C 6 -cycloalkenyl, C 7 -cycloalkenyl, C 8 -cycloalkenyl, C 9 -cycloalkenyl, C 10 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 21  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl C 6 -alkyl, C 2 -alkenyl, C 3 -alkenyl, C 4 -alkenyl, C 5 -alkenyl C 6 -alkenyl, C 2 -alkynyl, C 3 -alkynyl, C 4 -alkynyl, C 5 -alkynyl or C 6 -alkynyl, each of which is unsubstituted or substituted with one or two or three independently selected R 22 , OR 22 , NHR 22 , N(R 22 ) 2 , C(O)NH 2 , C(O)NHR 22 , C(O)N(R 22 ) 2 , OH, (O), C(O)OH, N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;    R 22  is R 23 , R 24  or R 25 ;    R 23  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 24  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl, 1,2,3-triazolyl, each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 25  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl or C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    Z 1  is R 26  or R 27 , each of which is substituted with R 28 , R 29  or R 30 , each of which is substituted with F, Cl, Br, I, CH 2 R 37 , CH(R 31 )(R 37 ), C(R 31 )(R 31A )(R 37 ), C(O)R 37 , OR 37 , SR 37 , S(O)R 37 , SO 2 R 37 , NHR 37  or N(R 32 )R 37 ;    R 26  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 27  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 28  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 29  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 30  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 7 -cycloalkyl, C 8 -cycloalkyl, C 9 -cycloalkyl, C 10 -cycloalkyl, C 11 -cycloalkyl, C 12 -cycloalkyl, C 13 -cycloalkyl, C 14 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl, C 6 -cycloalkenyl, C 7 -cycloalkenyl, C 8 -cycloalkenyl, C 9 -cycloalkenyl or C 10 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 31  and R 31A  are independently F, Cl, Br, C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl or are taken together and are C 2 -spiroalkyl, C 3 -spiroalkyl, C 4 -spiroalkyl or C 5 -spiroalkyl;    R 32  is R 33 , C(O)R 33  or C(O)OR 33 ;    R 33  is R 34  or R 35 ;    R 34  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 35  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl, each of which is unsubstituted or substituted with R 36 ;    R 36  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 37  is R 38 , R 39  or R 40 , each of which is substituted with F, Cl, Br, I, R 41  OR 41 , NHR 41 , N(R 41 ) 2 , NHC(O)OR 41 , SR 41 , S(O)R 41  or SO 2 R 41 ;    R 38  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 39  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 40  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 7 -cycloalkyl, C 8 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl, C 6 -cycloalkenyl, C 7 -cycloalkenyl or C 8 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 41  is R 42 , R 43 , R 44  or R 45 ;    R 42  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine, 1,2,3-triazole or R 42A ;    R 42A  is C 4 -cycloalkane, C 5 -cycloalkane, C 6 -cycloalkane, C 4 -cycloalkene, C 5 -cycloalkene or C 6 -cycloalkene, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 43  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 44  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl or C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N, and each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 45  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl C 6 -alkyl, C 2 -alkenyl, C 3 -alkenyl, C 4 -alkenyl, C 5 -alkenyl C 6 -alkenyl, C 2 -alkynyl, C 3 -alkynyl, C 4 -alkynyl, C 5 -alkynyl or C 6 -alkynyl, each of which is unsubstituted or substituted with one or two independently selected R 46 , OR 46 , NHR 46 , N(R 46 ) 2 , C(O)NH 2 , C(O)NHR 46 , C(O)N(R 46 ) 2 , OH, (O), C(O)OH, N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;    R 46  is R 47 , R 48  or R 49 ;    R 47  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 48  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 49  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl or C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    wherein the moieties represented by B 1  and Y 1  together are substituted with C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl, each of which is substituted with one or two independently selected SR 55  or N(R 55 ) 2  substituents, wherein R 55  is independently selected phenyl, C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl;    the moieties represented by R 2 , R 3  and R 4  are unsubstituted or substituted with one or two independently selected R 50 , OR 50 , SR 50 , SO 2 R 50 , CO(O)R 50  or OCF 3  substituents, wherein R 50  is phenyl, C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl;    the moieties represented by R 8 , R 9  and R 10  are unsubstituted or substituted with one or two independently selected R 50 , OR 50 , C(O)NHSO 2 R 50 , CO(O)R 50 , C(O)R 50 , C(O)OH, C(O)NHOH, OH, NH 2 , F, Cl, Br or I substituents, wherein R 50  is phenyl, tetrazolyl or R 54 , wherein R 54  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl, each of which is unsubstituted or substituted with phenyl;    the moieties represented by R 26  and R 27  are further unsubstituted or substituted with one or two independently selected F, Br, Cl or I substituents;    the moieties represented by R 28 , R 29  and R 30  are further unsubstituted or substituted with OR 54 , wherein R 54  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl, each of which is unsubstituted or substituted with R 56 , wherein R 56  is C 3 -cycloalkyl, C 4 -cycloalkyl C 5 -cycloalkyl or C 6 -cycloalkyl, each having one or two CH 2  moieties replaced with independently selected O or NH and one CH moiety unreplaced or replaced with N;    the moieties represented by R 38 , R 39  and R 40  are further unsubstituted or substituted with one or two independently selected R 54 , F, Br, Cl or I substituents, wherein R 54  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl; and    the moieties represented by R 42 , R 43 , R 44  and R 45  are unsubstituted or substituted with one or two independently selected R 50 , OR 50 , SR 50 , N(R 50 ) 2 , SO 2 R 50 , CN, CF 3 , F, Cl, Br or I substituents, wherein R 50  is phenyl or R 54 , wherein R 54  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl, each of which is unsubstituted or substituted with N(R 55 ) 2  or R 56 , wherein R 55  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl and R 56  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl or C 6 -cycloalkyl, each having one CH 2  moiety unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N.    
     
     
         3 . The compound of formula (I) according to  claim 2 , wherein A 1  is C(A 2 ); 
 A 2  is H, F, CN, C(O)OH, C(O)NH 2  or C(O)OR 1A ;    B 1  is R 1 , OR 1 , SR 1 , S(O)R 1 , SO 2 R 1 , C(O)R 1 , C(O)OR 1 , OC(O)R 1 , NHR 1 , N(R 1 ) 2 , C(O)NHR 1 , C(O)N(R 1 ) 2 , NHC(O)R 1 , NHC(O)OR 1 , NR 1 C(O)NHR 1 , NR 1 C(O)N(R 1 ) 2 , SO 2 NHR 1 , SO 2 N(R 1 ) 2 , NHSO 2 R 1 , NHSO 2 NHR 1  or N(CH 3 )SO 2 N(CH 3 )R 1 ;    D 1  is H, F, C 1  or CF 3 ;    E 1  is H, F or Cl;    Y 1  is H, CN, NO 2 , C(O)OH, F, Cl, Br, CF 3 , OCF 3 , NH 2 , C(O)NH 2 , or    B 1  and Y 1 , together with the atoms to which they are attached, are imidazole or triazole;    R 1  is R 2 , R 3 , R 4  or R 5 ;    R 1A  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl, C 6 -alkyl;    R 2  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 3  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene;    R 4  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl or C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 5  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl, C 6 -alkyl, C 2 -alkenyl, C 3 -alkenyl, C 4 -alkenyl, C 5 -alkenyl, C 6 -alkenyl, C 3 -alkynyl, C 4 -alkynyl, C 5 -alkynyl or C 6 -alkynyl, each of which is unsubstituted or substituted with one or two or three independently selected R 6 , R 7 , OR 7 , SR 7 , S(O)R 7 , SO 2 R 7 , NHR 7 , N(R 7 ) 2 , C(O)R 7 , C(O)NH 2 , C(O)NHR 7 , NHC(O)R 7 , NHSO 2 R 7 , NHC(O)OR 7 , SO 2 NH 2 , SO 2 NHR 7 , SO 2 N(R 7 ) 2 , NHC(O)NH 2 , NHC(O)NHR 7 , NHC(O)CH(CH 3 )NHC(O)CH(CH 3 )NH 2 , OH, (O), C(O)OH, (O), N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;    R 6  is C 2 -spiroalkyl, C 3 -spiroalkyl, C 4 -spiroalkyl or C 5 -spiroalkyl, each of which is unsubstituted or substituted with OH, (O), N 3 , CN, CF 3 , CF 2 CF 3 , F, Cl, Br, I, NH 2 , NH(CH 3 ) or N(CH 3 ) 2 ;    R 7  is R 8 , R 9 , R 10  or R 11 ;    R 8  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine, 1,2,3-triazole or R 8A ;    R 8A  is C 4 -cycloalkane, C 5 -cycloalkane, C 6 -cycloalkane, C 4 -cycloalkene, C 5 -cycloalkene or C 6 -cycloalkene, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 9  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene;    R 10  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 7 -cycloalkyl, C 8 -cycloalkyl, C 9 -cycloalkyl, C 10 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl, C 6 -cycloalkenyl, C 7 -cycloalkenyl, C 8 -cycloalkenyl, C 9 -cycloalkenyl, C 10 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 11  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl C 6 -alkyl, C 2 -alkenyl, C 3 -alkenyl, C 4 -alkenyl, C 5 -alkenyl C 6 -alkenyl, C 2 -alkynyl, C 3 -alkynyl, C 4 -alkynyl, C 5 -alkynyl or C 6 -alkynyl, each of which is unsubstituted or substituted with one or two or three independently selected R 12 , OR 12 , NHR 12 , N(R 12 ) 2 , C(O)NH 2 , C(O)NHR 12 , C(O)N(R 12 ) 2 , OH, (O), C(O)OH, N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;    R 12  is R 13 , R 14 , R 15  or R 16 ;    R 13  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine, 1,2,3-triazole or R 13A ;    R 13A  is C 4 -cycloalkane, C 5 -cycloalkane, C 6 -cycloalkane, C 4 -cycloalkene, C 5 -cycloalkene or C 6 -cycloalkene, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 14  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl, 1,2,3-triazolyl, each of which is unfused or fused with benzene;    R 15  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl or C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 16  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl C 6 -alkyl, C 2 -alkenyl, C 3 -alkenyl, C 4 -alkenyl, C 5 -alkenyl C 6 -alkenyl, C 3 -alkynyl, C 4 -alkynyl, C 5 -alkynyl or C 6 -alkynyl;    Z 1  is R 26  or R 27 , each of which is substituted with R 28 , R 29  or R 30 , each of which is substituted with Cl, Br, CH 2 R 37 , C(R 31 )(R 31A )(R 37 ), C(O)R 37 , OR 37 , SR 37 , S(O)R 37 , SO 2 R 37  or NHR 37 ;    R 26  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 27  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene;    R 28  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 29  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene;    R 30  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 7 -cycloalkyl, C 8 -cycloalkyl, C 9 -cycloalkyl, C 10 -cycloalkyl, C 11 -cycloalkyl, C 12 -cycloalkyl, C 13 -cycloalkyl, C 14 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl, C 6 -cycloalkenyl, C 7 -cycloalkenyl, C 8 -cycloalkenyl, C 9 -cycloalkenyl or C 10 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 31  and R 31A  are independently F, Cl, Br, C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl or are taken together and are C 2 -spiroalkyl, C 3 -spiroalkyl, C 4 -spiroalkyl or C 5 -spiroalkyl;    R 37  is R 38 , R 39  or R 40 , each of which is substituted with F, Cl, Br, I, R 41 , OR 41 , NHR 41 , N(R 41 ) 2 , NHC(O)R 41 , SR 41 , S(O)R 41  or SO 2 R 41 ;    R 38  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 39  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene;    R 40  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 7 -cycloalkyl, C 8 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl, C 6 -cycloalkenyl, C 7 -cycloalkenyl or C 8 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 41  is R 42 , R 43 , R 44  or R 45 ;    R 42  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine, 1,2,3-triazole or R 42A ;    R 42A  is C 4 -cycloalkane, C 5 -cycloalkane, C 6 -cycloalkane, C 4 -cycloalkene, C 5 -cycloalkene or C 6 -cycloalkene, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    R 43  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene;    R 44  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl or C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), CNOH, CNOCH 3 , S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N, and each of which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 45  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl C 6 -alkyl, C 2 -alkenyl, C 3 -alkenyl, C 4 -alkenyl, C 5 -alkenyl C 6 -alkenyl, C 2 -alkynyl, C 3 -alkynyl, C 4 -alkynyl, C 5 -alkynyl or C 6 -alkynyl, each of which is unsubstituted or substituted with one or two independently selected R 46 , OR 46 , NHR 46 , N(R 46 ) 2 , C(O)NH 2 , C(O)NHR 46 , C(O)N(R 46 ) 2 , OH, (O), C(O)OH, N 3 , CN, NH 2 , CF 3 , CF 2 CF 3 , F, Cl, Br or I substituents;    R 46  is R 47 , R 48  or R 49 ;    R 47  is phenyl which is unfused or fused with benzene, furan, imidazole, isothiazole, isoxazole, 1,2,3-oxadiazole, 1,2,5-oxadiazole, oxazole, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, thiazole, thiophene, triazine or 1,2,3-triazole;    R 48  is furanyl, imidazolyl, isothiazolyl, isoxazolyl, 1,2,3-oxadiazoyl, 1,2,5-oxadiazolyl, oxazolyl, pyrazinyl, pyrazolyl, pyridazinyl, pyridinyl, pyrimidinyl, pyrrolyl, tetrazolyl, thiazolyl, thienyl, triazinyl or 1,2,3-triazolyl, each of which is unfused or fused with benzene;    R 49  is C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, C 4 -cycloalkenyl, C 5 -cycloalkenyl or C 6 -cycloalkenyl, each having one or two CH 2  moieties unreplaced or replaced with independently selected O, C(O), S, S(O), SO 2  or NH and one or two CH moieties unreplaced or replaced with N;    wherein the moieties represented by B 1  and Y 1  together are substituted with C 2 -alkyl, C 3 -alkyl or C 4 -alkyl, each of which is substituted with one or two independently selected SR 55  or N(R 55 ) 2  substituents, wherein R 55  is independently selected phenyl or C 1 -alkyl;    the moieties represented by R 2 , R 3  and R 4  are unsubstituted or substituted with one or two independently selected R 50 , OR 50 , SR 50 , SO 2 R 50 , CO(O)R 50  or OCF 3  substituents, wherein R 50  is phenyl, C 1 -alkyl, C 2 -alkyl, C 3 -alkyl or C 4 -alkyl;    the moieties represented by R 8 , R 9  and R 10  are unsubstituted or substituted with one or two independently selected R 50 , OR 50 , C(O)NHSO 2 R 50 , CO(O)R 50 , C(O)R 50 , C(O)OH, C(O)NHOH, OH, NH 2 , F, Cl, Br or I substituents, wherein R 50  is phenyl, tetrazolyl or R 54 , wherein R 54  is C 1 -alkyl, C 2 -alkyl or C 3 -alkyl, each of which is unsubstituted or substituted with phenyl;    the moieties represented by R 26  and R 27  are further unsubstituted or substituted with one or two independently selected F, Br, Cl or I substituents;    the moieties represented by R 28 , R 29  and R 30  are further unsubstituted or substituted with OR 54 , wherein R 54  is C 1 -alkyl or C 2 -alkyl, each of which is unsubstituted or substituted with N(R 55 ) 2  or R 56 , wherein R 55  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl, and R 56  is C 5 -cycloalkyl or C 6 -cycloalkyl, each having one or two CH 2  moieties replaced with independently selected O or NH and one CH moiety unreplaced or replaced with N;    the moieties represented by R 38 , R 39  and R 40  are further unsubstituted or substituted with one or two independently selected C 1 -alkyl, F, Br, Cl or I substituents; and    the moieties represented by R 42 , R 43 , R 44  and R 45  are unsubstituted or substituted with one or two independently selected R 50 , OR 50 , SR 50 , N(R 50 ) 2 , SO 2 R 50 , CN, CF 3 , F, Cl, Br or I substituents, wherein R 50  is phenyl or R 54 , wherein R 54  is C 1 -alkyl, C 2 -alkyl or C 3 -alkyl, each of which is unsubstituted or substituted with N(C 1 -alkyl) 2  or C 6 -cycloalkyl having one CH 2  moiety replaced with 0 and one CH moiety replaced with N.    
     
     
         4 . The compound of formula (I) according to  claim 3 , wherein A 1  is C(A 2 ); 
 A 2  is H, F, CN, C(O)OH, C(O)NH 2  or C(O)OCH 3 ;    B 1  is R 1 , OR 1 , NHR 1 , N(R 1 ) 2  or NR 1 C(O)N(R 1 ) 2 ;    D 1  is H, F, C 1  or CF 3 ;    E 1  is H, F or Cl;    Y 1  is H, CN, NO 2 , F, Cl, CF 3 , OCF 3 , NH 2 , C(O)NH 2 , or    B 1  and Y 1 , together with the atoms to which they are attached, are imidazole or triazole;    R 1  is phenyl, pyrrolyl, C 5 -cycloalkyl, C 6 -cycloalkyl, piperidinyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydrothiopyranyl or R 5 ;    R 5  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl, C 4 -alkyl, C 5 -alkyl or C 6 -alkyl, each of which is unsubstituted or substituted with one or two or three independently selected C 4 -spiroalkyl, C 5 -spiroalkyl, R 7 , OR 7 , SR 7 , SO 2 R 7 , NHR 7 , N(R 7 ) 2 , C(O)R 7 , C(O)NH 2 , C(O)NHR 7 , NHC(O)R 7 , NHSO 2 R 7 , NHC(O)OR 7 , NHC(O)NH 2 , NHC(O)CH(CH 3 )NHC(O)CH(CH 3 )NH 2 , OH, C(O)OH or NH 2  substituents;    R 7  is phenyl, furanyl, imidazolyl, pyridinyl, tetrazolyl, thiazolyl, thienyl, 1,3-benzoxazolyl, 1,3-benzodioxolyl, 1,3-benzothiazole, C 3 -cycloalkyl, C 4 -cycloalkyl, C 5 -cycloalkyl, C 6 -cycloalkyl, azetidinyl, morpholinyl, piperazinyl, piperidinyl, thiomorpholinyl, thiomorpholinyl sulfone 7-azabicyclo[2.2.1]heptanyl, 8-azabicyclo[3.2.1]-octanyl, 4,5-dihydro-1H-imidazolyl 2-oxa-5-azabicyclo-[2.2.1]heptanyl, 1,4,5,6-tetrahydropyrimidinyl or R 11 ;    R 11  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl or C 4 -alkyl, each of which is unsubstituted or substituted with one or two or three independently selected R 12 , OR 12 , N(R 12 ) 2 , C(O)N(R 12 ) 2 , OH, C(O)OH, NH 2 , CF 3 , F, Cl, Br or I substituents;    R 12  is 1,3-benzodioxolyl, pyridinyl, morpholinyl or C 1 -alkyl;    Z 1  is phenyl or pyridinyl, each of which is substituted with C 6 -cycloalkenyl, piperazinyl, piperidinyl, 1,2,3,6-tetrahydropyridinyl or octahydropyrrolo[3,4-c]pyrrolyl, each of which is substituted with CH 2 R 37 , C(C 2 -spiroalkyl)(R 37 ) or C(O)R 37 ;    R 37  is phenyl, naphthyl, imidazolyl, pyrazolyl, pyridinyl, C 5 -cycloalkenyl, C 6 -cycloalkenyl, C 7 -cycloalkenyl, C 8 -cycloalkenyl or 3,6-dihydro-2H-pyranyl, each of which is substituted with F, Cl, Br, I, R 41 , NHR 41 , N(R 41 ) 2 , NHC(O)OR 41  or SR 41 ;    R 41  is phenyl, naphthyl, cyclohexyl, morpholinyl, piperidinyl, thienyl, pyridinyl, quinolinyl, benzofuranyl, 1,3-benzodioxolyl, isoindolinyl, 1,3-oxazolidin-2-onyl or R 45 ;    R 45  is C 1 -alkyl, C 2 -alkyl, C 3 -alkyl or C 4 -alkyl, each of which is unsubstituted or substituted with phenyl;    wherein the moieties represented by B 1  and Y 1  together are substituted with C 2 -alkyl, C 3 -alkyl or C 4 -alkyl, each of which is substituted with one or two independently selected SR 55  or N(R 55 ) 2  substituents, wherein R 55  is independently selected phenyl or C 1 -alkyl;    the moieties represented by R 1  are unsubstituted or substituted with one or two independently selected R 50 , OR 50 , SR 50 , SO 2 R 50 , CO(O)R 50  or OCF 3  substituents, wherein R 50  is phenyl, C 1 -alkyl, C 2 -alkyl, C 3 -alkyl or C 4 -alkyl;    the moieties represented by R 7  are unsubstituted or substituted with one or two independently selected R 50 , OR 50 , C(O)NHSO 2 R 50 , CO(O)R 50 , C(O)R 50 , C(O)OH, C(O)NHOH, OH, NH 2 , F, Cl, Br or I substituents, wherein R 50  is phenyl, tetrazolyl or R 54 , wherein R 54  is C 1 -alkyl, C 2 -alkyl or C 3 -alkyl, each of which is unsubstituted or substituted with phenyl;    the phenyl and pyridinyl moieties of Z 1  are further unsubstituted or substituted with one or two independently selected F, Br, Cl or I substituents;    the C 6 -cycloalkenyl, piperazinyl, piperidinyl, 1,2,3,6-tetrahydropyridinyl and octahydropyrrolo[3,4-c]pyrrolyl moieties of Z 1  are further unsubstituted or substituted with OR 54 , wherein R 54  is C 1 -alkyl or C 2 -alkyl, each of which is unsubstituted or substituted with N(C 1 -alkyl) 2 , morpholinyl, piperidinyl or piperidinyl;    the moieties represented by R 37  are further unsubstituted or substituted with one or two independently selected C 1 -alkyl, F, Br, Cl or I substituents; and    the moieties represented by R 41  are unsubstituted or substituted with one or two independently selected R 50 , OR 50 , SR 50 , N(R 50 ) 2 , SO 2 R 50 , CN, CF 3 , F, Cl, Br or I substituents, wherein R 50  is phenyl or R 54 , wherein R 54  is C 1 -alkyl, C 2 -alkyl or C 3 -alkyl, each of which is unsubstituted or substituted with N(C 1 -alkyl) 2  or morpholinyl.    
     
     
         5 . A composition for treating bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancies of T-cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, prostate cancer, small cell lung cancer or spleen cancer, said composition comprising an excipient and a therapeutically effective amount of the compound of  claim 1 .  
     
     
         6 . A method of treating bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancies of T-cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, prostate cancer, small cell lung cancer or spleen cancer in a patient, said method comprising administering to the patient a therapeutically effective amount of a compound of  claim 1 .  
     
     
         7 . A method of treating bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancies of T-cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, prostate cancer, small cell lung cancer or spleen cancer in a patient, said method comprising administering to the patient a therapeutically effective amount of N-(4-(4-((4′-chloro(1,1′-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide, or a therapeutically acceptable salt, prodrug or salt of a prodrug thereof.  
     
     
         8 . A method of treating bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancies of T-cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, prostate cancer, small cell lung cancer or spleen cancer in a patient, said method comprising administering to the patient therapeutically effective amount of the compound of  claim 1  and a therapeutically effective amount of one additional therapeutic agent or more than one additional therapeutic agent.  
     
     
         9 . A method of treating bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, esophageal cancer, hepatocellular cancer, lymphoblastic leukemia, follicular lymphoma, lymphoid malignancies of T-cell or B-cell origin, melanoma, myelogenous leukemia, myeloma, oral cancer, ovarian cancer, non-small cell lung cancer, prostate cancer, small cell lung cancer or spleen cancer in a patient, said method comprising administering to the patient a therapeutically effective amount of N-(4-(4-((4′-chloro(1,1′-biphenyl)-2-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)-propyl)amino)-3-nitrobenzenesulfonamide, or a therapeutically acceptable salt, prodrug or salt of a prodrug thereof, and a therapeutically effective amount of one additional therapeutic agent or more than one additional therapeutic agent.